Publications

  1. Stoll KA, Mackison A, Allyse MA, Michie M. Conflicts of interest in genetic counseling: acknowledging and accepting. Genet Med. 2017 Aug; 19 (8):864-866 Epub 2017 Jan 26
    View PubMed
  2. Allyse M, Wick MJ. What do the new American College of Medical Genetics and Genomics (ACMG) guidelines mean for the provision of non-invasive prenatal genetic screening? J Obstet Gynaecol. 2017 Aug; 37: (6)795-798.
    View PubMed
  3. Allyse M, Aypar U, Bonhomme N, Darilek S, Dougherty M, Farrell R, Grody W, Highsmith WE, Michie M, Nunes M, Otto L, Pabst R, Palomaki G, Runke C, Sharp RR, Skotko B, Stoll K, Wick M. Offering Prenatal Screening in the Age of Genomic Medicine: A Practical Guide. J Womens Health (Larchmt). 2017 Jul; 26: (7)755-761.
    View PubMed
  4. Sperry BP, Allyse M, Sharp RR. Genetic Fingerprints and National Security. Am J Bioeth. 2017 May; 17: (5)1-3.
    View PubMed
  5. Mozersky J, Ravitsky V, Rapp R, Michie M, Chandrasekharan S, Allyse M. Toward an Ethically Sensitive Implementation of Noninvasive Prenatal Screening in the Global Context Hastings Center Report.2017;47(2)41-49.
  6. Mozersky J, Ravitsky V, Rapp R, Michie M, Chandrasekharan S, Allyse M. Toward an Ethically Sensitive Implementation of Noninvasive Prenatal Screening in the Global Context. Hastings Cent Rep. 2017 Mar; 47: (2)41-49.
    View PubMed
  7. Parham L, Michie M, Allyse M. Expanding Use of cfDNA Screening in Pregnancy: Current and Emerging Ethical, Legal, and Social Issues Current Genetic Medicine Reports.02/11/2017;
  8. Li G, Chandrasekharan S, Allyse M. "The Top Priority Is a Healthy Baby": Narratives of Health, Disability, and Abortion in Online Pregnancy Forum Discussions in the US and China. J Genet Couns. 2017 Feb; 26 (1):32-39 Epub 2016 June 09
    View PubMed
  9. Tilburt JC, Allyse M, Hafferty FW. The Case of Dr. Oz: Ethics, Evidence, and Does Professional Self-Regulation Work? AMA J Ethics. 2017 Feb 01; 19 (2):199-206
    View PubMed
  10. Allyse M, Evans JP, Michie M. Dr. Pangloss's Clinic: Prenatal Whole Genome Sequencing and a Return to Reality. Am J Bioeth. 2017 Jan; 17 (1):21-23
    View PubMed
  11. Allyse M, Hafferty F, Tilburt J. Sanctioning Oz (Almost): Quandaries and Ironies In the Ethics of Professional Self-Regulation. AMA Journal of Ethics.2016;().
  12. Floyd E, Allyse MA, Michie M. Spanish- and English-Speaking Pregnant Women's Views on cfDNA and Other Prenatal Screening: Practical and Ethical Reflections. J Genet Couns. 2016 Oct; 25 (5):965-77 Epub 2016 Jan 07
    View PubMed
  13. Meredith S, Kaposy C, Miller VJ, Allyse M, Chandrasekharan S, Michie M, Prenatal Testing PAG Coalition. Impact of the increased adoption of prenatal cfDNA screening on non-profit patient advocacy organizations in the United States. Prenat Diagn. 2016 Aug; 36 (8):714-9 Epub 2016 July 18
    View PubMed
  14. Michie M, Kraft SA, Minear MA, Ryan RR, Allyse MA. Informed decision-making about prenatal cfDNA screening: An assessment of written materials. Ethics Med Public Health. 2016 Jul-Sep; 2 (3):362-371 Epub 2016 Sept 13
    View PubMed
  15. Gammon BL, Kraft SA, Michie M, Allyse M. "I think we've got too many tests!": Prenatal providers' reflections on ethical and clinical challenges in the practice integration of cell-free DNA screening. Ethics Med Public Health. 2016 Jul-Sep; 2 (3):334-342
    View PubMed
  16. Li G., Allyse M. Experiences of Mandarin-speaking and English-speaking women of undergoing non-invasive prenatal genetic screening. Ethics, Medicine and Public Health.2016;2:(3):372-82.
  17. Steinbach RJ, Allyse M, Michie M, Liu EY, Cho MK. "This lifetime commitment": Public conceptions of disability and noninvasive prenatal genetic screening. Am J Med Genet A. 2016 Feb; 170A: (2)363-74.
    View PubMed
  18. Allyse M. The Age of Unreason: A Review of Jane Maienschein, Embryos Under the Microscope. Am J Bioeth. 2016 Feb; 16: (2)W1-2.
    View PubMed
  19. Allyse M. Non-invasive prenatal testing in the non-Western context BioNews.2016;
  20. Michie M, Allyse M. Old Questions, New Paradigms: Ethical, Legal and Social Complications of Non-Invasive Prenatal Testing. AJOB Empirical Bioethics. 2015; 6(1).
  21. Allyse M, Sayres LC, Michie M, Goodspeed T, Cho M. Don't want no risk, don't want no problems: Public understandings of the risks and benefits of novel prenatal technologies in the United States. AJOB Empirical Bioethics.2015;6:(1):5-20.
    View PubMed
  22. Allyse MA, McCormick JB, Sharp RR. Prudentia Populo: Involving the Community in Biobank Governance. Am J Bioeth. 2015; 15: (9)1-3.
    View PubMed
  23. Minear MA, Alessi S, Allyse M, Michie M, Chandrasekharan S. Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues. Annu Rev Genomics Hum Genet. 2015; 16:369-98.
    View PubMed
  24. Sayres LC, Allyse M, Goodspeed T, Cho MK. Demographic and Experiential Predictors of Public Attitudes towards Cell-Free Fetal DNA Journal of Genetic Counseling.0;23:(6):957-67.
    View PubMed
  25. Chandresekharan S, Minear M, Hung A, Allyse M. Noninvasive prenatal testing goes global. Science Translational Medicine.2014;
  26. Allyse M, Sayres LC, Goodspeed T, Cho MK. Attitudes Towards Non-Invasive Prenatal Testing Among US Adults of Reproductive Age Journal of Perinatology. 2014 March 6.
  27. Allyse M, Minear M, Berson E, Rote M, Sidhar S, Hung A, Chandresekharan S. Non-Invasive Prenatal Testing: A review of international implementation and challenges International Journal of Women's Health. 2014.
  28. Constantine M, Allyse M, Wall M, De Vries R, Rockwood TH. Imperfect Informed Consent in Non-Invasive Prenatal Testing: Lessons from the quad screen. Clinical Ethics.2013;
  29. Berryessa C, Martinex-Martin N, Allyse M. Ethical, Legal and Social Issues Surrounding Research on Genetic Contributions to Anti-Social Behavior Aggression and Violent Behavior.2013;605-610.
  30. Allyse M, Scott C. Too much of a good thing Nature Biotech. 2013:597-598.
  31. Allyse M, Sayres LC, Havard M, Norton ME, Hudgins L, Taylor J, King JS, Cho MK, Greely HT, Magnus D, Ormond KE. Best Practices in the Provision of Non-Invasive Prenatal Diagnosis Prenatal Diagnosis. 2013:656-61.
  32. Allyse M, Michie M. Not-so-incidental-findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing Trends in Biotechnology. 2013:439-41.
  33. Allyse M. 23andMe, We and You: Direct-to-consumer genetics, intellectual property and informed consent Trends in Biotechnology. 2013:68-69.
  34. Goodspeed T, Allyse M, Sayres L, Norton ME, Cho MK. Translating Cell-Free Fetal DNA Trends in Biotechnology.2013;7-9.
  35. Allyse M, Sayres L, Norton M, King JS, Cho MK. Cell-free fetal DNA testing for fetal aneuploidy and beyond: Clinical integration challenges in the United States context Human Reproduction. 2012:3123-3131.
  36. Sayres LC, Allyse M, Goodspeed T, Cho MK. In the public interest? Consequences of broad patenting and restrictive licensing for cell-free fetal DNA testing Science Translational Medicine.2012;
  37. Sayres LC, Allyse M, Cho MK. Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy. Genome Medicine.2012;49.
  38. Tobin SL, Cho MK, Lee SSJ, Magnus D, Allyse M, Ormond KE, Garrison N. Customers or Research Participants? Guidance for Research Practices in Commercialization of Personal Genomics Genetics in Medicine. 2012:833-835.
  39. Allyse M, Karkazis K, Lee SSJ, Tobin SL, Greely HT, Cho MK, Magnus D. Informational Risk, Institutional Review, and Autonomy in the Proposed Changes to the Common Rule IRB: Ethics & Human Research. 2012.
  40. Sayres LC, Allyse M, Norton ME, Cho MK. Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation Prenat Diagnosis.2011;1070-6.
  41. Allyse M, Milner LC, Cho MK. Ethics watch: the G.I. genome: ethical implications of genome sequencing in the military Nature Reviews Genetics. 2011; Ethics watch:589.
  42. Allyse M. Embryos, Ethics and Expertise: the emerging model of the scientific research ethics regulator Science and Public Policy. 2010:597-610.